Lantern Pharma Inc. (LTRN) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Lantern Pharma Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.596 We will open the call for questions and answers after our management's presentation. 00:00:04.596 -- 00:00:09.621 A webcast replay of today's conference call will be available on our website at lanternpharma.com 00:00:09.621 -- 00:00:14.507 shortly after the call. We issued a press release before market opened today, summarizing 00:00:14.507 -- 00:00:18.391 our financial results and progress across the company for the second quarter ended June 00:00:18.391 -- 00:00:20.373 30, 2026. 00:00:20.373 -- 00:00:24.436 A copy of this release is available through our website at lanternpharma.com 00:00:24.436 -- 00:00:28.019 where you will also find a link to the slides management will be referencing on today's 00:00:28.019 -- 00:00:33.083 call. We would like to remind everyone that remarks about future expectations, performance, 00:00:33.083 -- 00:00:37.966 estimates, and prospects constitute forward-looking statements for purposes of safe harbor 00:00:37.966 -- 00:00:43.010 provisions under the Private Securities Litigation Reform Act of 1995. 00:00:43.010 -- 00:00:47.014 Lantern Pharma cautions that these forward-looking statements are subject to risks and 00:00:47.014 -- 00:00:51.838 uncertainties that may cause actual results to differ materially from those anticipated. 00:00:51.838 -- 00:00:55.922 A number of factors could cause actual results to differ materially from those indicated 00:00:55.922 -- 00:01:00.486 by forward-looking statements, including results of clinical trials and the impact of 00:01:00.486 -- 00:01:01.987 competition. 00:01:01.987 -- 00:01:06.351 Additional information concerning factors that could cause actual results to differ materially 00:01:06.351 -- 00:01:10.555 from those in the forward-looking statements can...